Bio-Gene Technology

Bio-Gene Technology Treasury Stock

The Treasury Stock of Bio-Gene Technology (BGT.AX) as of Oct 23, 2026 is 712,090.00 AUD. In the previous year, Treasury Stock was 818,450.00 AUD — a change of -13.00% (lower).

Treasury Stock

712,090.00AUD

YoY

-13.00%

Last updated:

Treasury Stock of Bio-Gene Technology is 2024 712,090.00 AUD. Treasury Stock of Bio-Gene Technology was 2023 818,450.00 AUD. It decreases by -13.00% lower compared to the previous year.

The Bio-Gene Technology Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2017
366,053.00 AUD
Jan 1, 2018
633,823.00 AUD
Jan 1, 2019
695,849.00 AUD
Jan 1, 2020
950,002.00 AUD
Jan 1, 2021
863,329.00 AUD
Jan 1, 2022
1.22 M AUD
Jan 1, 2023
818,450.00 AUD
Jan 1, 2024
712,090.00 AUD
The Bio-Gene Technology Treasury Stock history
YEARTreasury StockYoY
712,090.00AUD-13.00%
818,450.00AUD-33.01%
1.22 MAUD+41.52%
863,329.00AUD-9.12%
950,002.00AUD+36.52%
695,849.00AUD+9.79%
633,823.00AUD+73.15%
366,053.00AUD+21.50%
301,268.00AUD—
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology Ltd develops and commercializes insecticides using beta-triketone platform technology. The company's lead products are Flavocide, a chemically synthesized insecticide based on flavesone, and Qcide, a natural oil product containing tasmanone extracted from Gympie Messmate leaves via steam distillation. These products address insecticide resistance and toxicity issues in crop protection, storage, public health, animal health, and consumer applications. Insecticide manufacturers purchase the company's platform technology and products for commercialization across multiple sectors. The firm's beta-triketone platform provides multiple solutions for insecticide manufacturers seeking to develop novel pest control products. Flavocide and Qcide represent the company's primary commercial offerings, with Flavocide targeting synthetic insecticide markets and Qcide focusing on natural oil-based solutions. The company's technology enables the development of targeted insect control solutions for various applications including agricultural crop protection and public health management. Bio-Gene Technology Ltd. aims to develop a portfolio of targeted insect control solutions for insecticide manufacturers. The company's platform technology allows manufacturers to create new products addressing resistance and toxicity challenges. Through its two lead products, the company provides both synthetic and natural options for the insecticide market, targeting manufacturers who seek innovative solutions for pest management across different industry segments. Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

Treasury Stock of Bio-Gene Technology is 712,090.00 AUD in 2024.

Treasury Stock of Bio-Gene Technology changed from 818,450.00 AUD to 712,090.00 AUD, representing a -13.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Bio-Gene Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bio-Gene Technology

All Key Metrics — Bio-Gene Technology